167 related articles for article (PubMed ID: 8855716)
1. [Mechanisms of cytotoxic drug-induced emesis and its prevention].
Matsuki N
Yakugaku Zasshi; 1996 Sep; 116(9):710-8. PubMed ID: 8855716
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
Cubeddu LX
Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of antiemetic effect of various dosage regimens of azasetron hydrochloride based on 5-HT3 receptor occupancy of serotonin].
Yamada Y; Fujita M; Okuyama K; Takayanagi R; Ozeki T; Yokoyama H; Iga T
Yakugaku Zasshi; 2007 Feb; 127(2):353-7. PubMed ID: 17268155
[TBL] [Abstract][Full Text] [Related]
5. [Serotonin and anticancer drug-induced emesis].
Minami M; Endo T; Hamaue N; Hirafuji M
Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Gregory RE; Ettinger DS
Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
[TBL] [Abstract][Full Text] [Related]
7. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.
Cubeddu LX
Oncology; 1996 Jun; 53 Suppl 1():18-25. PubMed ID: 8692546
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).
De Jonghe BC; Horn CC
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R902-11. PubMed ID: 19225146
[TBL] [Abstract][Full Text] [Related]
9. [Role of serotonin in emesis].
Minami M; Endo T; Hirafuji M
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):233-42. PubMed ID: 8974084
[TBL] [Abstract][Full Text] [Related]
10. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of ondansetron in acute and delayed cisplatin-induced nausea and vomiting].
Depierre A
Bull Cancer; 1996 Feb; 83(2):147-53. PubMed ID: 8652909
[TBL] [Abstract][Full Text] [Related]
12. Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew).
Ullah I; Subhan F; Lu Z; Chan SW; Rudd JA
J Pharmacol Sci; 2017 Apr; 133(4):232-239. PubMed ID: 28363413
[TBL] [Abstract][Full Text] [Related]
13. Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy.
Karim F; Roerig SC; Saphier D
Biochem Pharmacol; 1996 Sep; 52(5):685-92. PubMed ID: 8765466
[TBL] [Abstract][Full Text] [Related]
14. Management of other non-cisplatin-induced emesis.
Schmoll HJ; Casper J
Oncology; 1996 Jun; 53 Suppl 1():51-5. PubMed ID: 8692552
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus.
Torii Y; Saito H; Matsuki N
Jpn J Pharmacol; 1991 Jan; 55(1):107-13. PubMed ID: 2041220
[TBL] [Abstract][Full Text] [Related]
16. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology of emesis in relation to clinical response.
Costall B; Naylor RJ
Br J Cancer Suppl; 1992 Dec; 19():S2-7; discussion S7-8. PubMed ID: 1467196
[TBL] [Abstract][Full Text] [Related]
18. Male/female differences in drug-induced emesis and motion sickness in Suncus murinus.
Matsuki N; Wang CH; Okada F; Tamura M; Ikegaya Y; Lin SC; Hsu YN; Chaung LJ; Chen SJ; Saito H
Pharmacol Biochem Behav; 1997 Aug; 57(4):721-5. PubMed ID: 9258999
[TBL] [Abstract][Full Text] [Related]
19. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis.
Ossi M; Anderson E; Freeman A
Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556
[TBL] [Abstract][Full Text] [Related]
20. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
